These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24968925)

  • 1. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles.
    Nguyen HT; Tran TH; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2015; 38(5):716-24. PubMed ID: 24968925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG)-loaded poly(lactic acid-co-glycolic acid) nanoparticles.
    Pradhan R; Poudel BK; Choi JY; Choi IS; Shin BS; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2015; 38(5):734-41. PubMed ID: 24824337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(D,L-lactic-co-glycolic acid)-based artesunate nanoparticles: formulation, antimalarial and toxicity assessments.
    Dauda K; Busari Z; Morenikeji O; Afolayan F; Oyeyemi O; Meena J; Sahu D; Panda A
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):977-985. PubMed ID: 29119735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
    Sankar R; Ravikumar V
    Biomed Pharmacother; 2014 Sep; 68(7):865-71. PubMed ID: 25107842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
    Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of electrosprayed artesunate-loaded core-shell nanoparticles.
    Ho HN; Laidmäe I; Kogermann K; Lust A; Meos A; Nguyen CN; Heinämäki J
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1134-1142. PubMed ID: 28277847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
    Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
    Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, evaluation, and
    Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
    Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
    Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier.
    Nair KL; Thulasidasan AK; Deepa G; Anto RJ; Kumar GS
    Int J Pharm; 2012 Apr; 425(1-2):44-52. PubMed ID: 22266528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
    Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
    Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A.
    Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
    Mukerjee A; Vishwanatha JK
    Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.